lunes, 16 de marzo de 2020

Mending the broken social contract for pharma pricing, innovation - STAT

Mending the broken social contract for pharma pricing, innovation - STAT

First Opinion

Mending the broken social contract for pharmaceutical pricing and innovation

By JAMES C. ROBINSON


ADOBE
An implicit social contract binds the pharmaceutical industry, payers, and policymakers. That contract is in serious disrepair and must be redrawn.

No hay comentarios: